Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10708127rdf:typepubmed:Citationlld:pubmed
pubmed-article:10708127lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:10708127lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10708127lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:10708127lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:10708127lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:10708127lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:10708127lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:10708127pubmed:issue4lld:pubmed
pubmed-article:10708127pubmed:dateCreated2000-3-23lld:pubmed
pubmed-article:10708127pubmed:abstractTextLymphocyte activation and infiltration into a transplanted organ is an integral component of the rejection process. Graft infiltration of lymphocytes requires adhesion of leukocytes to the endothelium, diapedesis, and transmigration. One of several proteins involved in this process is CD44, which is known to interact with endothelial hyaluronan (HA). Blockade of cell-matrix and cell-cell interactions have been used extensively for modulation of immune responses and graft rejection. Based on these observations, we evaluated the effects of blocking CD44-HA interactions in a transplantation model.lld:pubmed
pubmed-article:10708127pubmed:languageenglld:pubmed
pubmed-article:10708127pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10708127pubmed:citationSubsetIMlld:pubmed
pubmed-article:10708127pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10708127pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10708127pubmed:statusMEDLINElld:pubmed
pubmed-article:10708127pubmed:monthFeblld:pubmed
pubmed-article:10708127pubmed:issn0041-1337lld:pubmed
pubmed-article:10708127pubmed:authorpubmed-author:LieTTlld:pubmed
pubmed-article:10708127pubmed:authorpubmed-author:ChenHHlld:pubmed
pubmed-article:10708127pubmed:authorpubmed-author:DalozePPlld:pubmed
pubmed-article:10708127pubmed:authorpubmed-author:LángJJlld:pubmed
pubmed-article:10708127pubmed:authorpubmed-author:XuDDlld:pubmed
pubmed-article:10708127pubmed:authorpubmed-author:GanMMlld:pubmed
pubmed-article:10708127pubmed:authorpubmed-author:PyBBlld:pubmed
pubmed-article:10708127pubmed:authorpubmed-author:ZhangWWlld:pubmed
pubmed-article:10708127pubmed:authorpubmed-author:BuelowRRlld:pubmed
pubmed-article:10708127pubmed:issnTypePrintlld:pubmed
pubmed-article:10708127pubmed:day27lld:pubmed
pubmed-article:10708127pubmed:volume69lld:pubmed
pubmed-article:10708127pubmed:ownerNLMlld:pubmed
pubmed-article:10708127pubmed:authorsCompleteYlld:pubmed
pubmed-article:10708127pubmed:pagination665-7lld:pubmed
pubmed-article:10708127pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:meshHeadingpubmed-meshheading:10708127...lld:pubmed
pubmed-article:10708127pubmed:year2000lld:pubmed
pubmed-article:10708127pubmed:articleTitleBlocking of CD44-hyaluronic acid interaction prolongs rat allograft survival.lld:pubmed
pubmed-article:10708127pubmed:affiliationSangStat Medical Corporation, Fremont, California 94555, USA.lld:pubmed
pubmed-article:10708127pubmed:publicationTypeJournal Articlelld:pubmed